Roche loses yet another Cipla battle

Swiss pharma firm, Hoffman-La Roche represented by IP lawyers Anand and Anand, have been dealt a major blow with the Chennai Patent Office deciding against its patent relating to anti-viral drug Valcyte. In the post-grant opposition filed by various Indian pharma companies, patent controller S.P. Balasubramanium ruled against Roche stating that Valcyte lacked inventive step.